Unmet medical needs in metastatic lung and digestive neuroendocrine neoplasms.
Authors
Capdevila, JBodei, L
Davies, P
Gorbounova, V
Jensen, R
Knigge, U
Krejs, G
Krenning, E
O'Connor, J
Peeters, M
Rindi, G
Salazar, R
Vullierme, M
Pavel, M
The ENETS 2016 Munich Advisory Board Participants
Valle, Juan W
Affiliation
Vall Hebron University Hospital, Vall Hebron Institute of Oncology (VHIO), BarcelonaIssue Date
2019
Metadata
Show full item recordAbstract
Unmet medical needs are not infrequent in oncology, and these needs are usually of higher magnitude in rare cancers. The field of neuroendocrine neoplasms (NENs) has evolved rapidly during the last decade, and, currently, a new WHO classification is being implemented and several treatment options are available in the metastatic setting after the results of prospective phase III clinical trials. However, several questions are still unanswered, and decisions in our daily clinical practice should be made with limited evidence. In the 2016 meeting of the advisory board of the European Neuroendocrine Tumor Society (ENETS), the main unmet medical needs in the metastatic NENs setting were deeply discussed, and several proposals to try to solve them are presented in this article, including biomarkers, imaging, and therapy.Citation
Capdevila J, Bodei L, Davies P, Gorbounova V, Jensen RT, Knigge UP, et al. Unmet medical needs in metastatic lung and digestive neuroendocrine neoplasm. Neuroendocrinology. 2019;108(1):18-25.Journal
NeuroendocrinologyDOI
10.1159/000493319PubMed ID
30153686Additional Links
https://dx.doi.org/10.1159/000493319Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1159/000493319
Scopus Count
Collections
Related articles
- Unmet Needs in Functional and Nonfunctional Pancreatic Neuroendocrine Neoplasms.
- Authors: Jensen RT, Bodei L, Capdevila J, Couvelard A, Falconi M, Glasberg S, Kloppel G, Lamberts S, Peeters M, Rindi G, Rinke A, Rothmund M, Sundin A, Welin S, Fazio N, The ENETS 2016 Munich Advisory Board Participants, ENETS 2016 Munich Advisory Board Participants
- Issue date: 2019
- Immunotherapy and potential predictive biomarkers in the treatment of neuroendocrine neoplasia.
- Authors: Xu G, Wang Y, Zhang H, She X, Yang J
- Issue date: 2021 Mar
- [Consensus and controversy of endoscopic diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors].
- Authors: Chen H, Chen Y
- Issue date: 2017 Sep 25
- Unmet Medical Needs in Pulmonary Neuroendocrine (Carcinoid) Neoplasms.
- Authors: Baudin E, Hayes AR, Scoazec JY, Filosso PL, Lim E, Kaltsas G, Frilling A, Chen J, Kos-Kudła B, Gorbunova V, Wiedenmann B, Nieveen van Dijkum E, Ćwikła JB, Falkerby J, Valle JW, Kulke MH, Caplin ME, ENETS 2016 Munich Advisory Board Participants, ENETS 2016 Munich Advisory Board Participants
- Issue date: 2019
- Diagnosis and workup of 522 consecutive patients with neuroendocrine neoplasms in Switzerland.
- Authors: Gouffon M, Iff S, Ziegler K, Larche M, Schwarzenbach C, Prior JO, Matter M, Stettler C, Pralong FP
- Issue date: 2014 Feb 19